1. Home
  2. NTST vs IMCR Comparison

NTST vs IMCR Comparison

Compare NTST & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTST
  • IMCR
  • Stock Information
  • Founded
  • NTST 2019
  • IMCR 2008
  • Country
  • NTST United States
  • IMCR United Kingdom
  • Employees
  • NTST N/A
  • IMCR N/A
  • Industry
  • NTST Real Estate Investment Trusts
  • IMCR Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • NTST Real Estate
  • IMCR Health Care
  • Exchange
  • NTST Nasdaq
  • IMCR Nasdaq
  • Market Cap
  • NTST 1.3B
  • IMCR 1.5B
  • IPO Year
  • NTST 2020
  • IMCR 2021
  • Fundamental
  • Price
  • NTST $16.70
  • IMCR $31.34
  • Analyst Decision
  • NTST Strong Buy
  • IMCR Buy
  • Analyst Count
  • NTST 8
  • IMCR 10
  • Target Price
  • NTST $18.16
  • IMCR $58.13
  • AVG Volume (30 Days)
  • NTST 916.9K
  • IMCR 560.7K
  • Earning Date
  • NTST 07-28-2025
  • IMCR 08-07-2025
  • Dividend Yield
  • NTST 5.00%
  • IMCR N/A
  • EPS Growth
  • NTST N/A
  • IMCR N/A
  • EPS
  • NTST N/A
  • IMCR N/A
  • Revenue
  • NTST $171,021,000.00
  • IMCR $333,581,000.00
  • Revenue This Year
  • NTST $12.84
  • IMCR $26.82
  • Revenue Next Year
  • NTST $6.47
  • IMCR $8.15
  • P/E Ratio
  • NTST N/A
  • IMCR N/A
  • Revenue Growth
  • NTST 22.05
  • IMCR 25.75
  • 52 Week Low
  • NTST $13.42
  • IMCR $23.15
  • 52 Week High
  • NTST $17.53
  • IMCR $41.54
  • Technical
  • Relative Strength Index (RSI)
  • NTST 65.50
  • IMCR 40.28
  • Support Level
  • NTST $16.14
  • IMCR $35.10
  • Resistance Level
  • NTST $16.55
  • IMCR $37.56
  • Average True Range (ATR)
  • NTST 0.31
  • IMCR 1.74
  • MACD
  • NTST 0.04
  • IMCR -0.79
  • Stochastic Oscillator
  • NTST 79.92
  • IMCR 0.75

About NTST NetSTREIT Corp.

Netstreit Corp is an internally managed real estate investment trust. The company acquires, owns, and manages single-tenant, retail commercial real estate subject to long-term net leases with high-credit quality tenants across the United States. It focuses on tenants in industries where a physical location is critical to the generation of sales and profits, with a focus on necessity goods and essential services in the retail sector, including home improvement, auto parts, drug stores and pharmacies, general retail, grocers, convenience stores, discount stores, and quick-service restaurants. Majorily operates in U.S. States and Other counties, and derives maximum of revenue from USA.

About IMCR Immunocore Holdings plc

Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.

Share on Social Networks: